WHO ICTRP trial
A clinical study to study the effects of the drug TZP-101 in patients with…
CTRI/2008/091/000254 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2008/091/000254 |
|---|---|
| Public title | A clinical study to study the effects of the drug TZP-101 in patients with severe gastroparesis (delayed gastric emptying)due to Diabetes Mellitus |
| Scientific title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute I.V. Infusion to Subjects with Severe Gastroparesis due to Diabetes Mellitus |
| Primary sponsor | Tranzyme Inc |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India;Denmark;Norway;Sweden;United Kingdom;United States of America |
| Conditions | Health Condition 1: null- Severe gastroparesis due to Diabetes Mellitus |
| Interventions | Intervention1: TZP-101: 40/80/160/320/600 micrograms/kg iv 2ml/minute for 30 minutes 1 infusion/day for 4 consecutive days Control Intervention1: Placebo - 5% dextrose in water: 60 ml IV infusion over 30 minutes |
| Registration date | Nov 28, 2008 |
| Target size | 78 |
| Secondary IDs | NCT00612014;TZP-01-CL-G004 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: